These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27295347)

  • 1. Cognitive and brain reserve in conversion and reversion in patients with mild cognitive impairment over 12 months of follow-up.
    Osone A; Arai R; Hakamada R; Shimoda K
    J Clin Exp Neuropsychol; 2016 Dec; 38(10):1084-93. PubMed ID: 27295347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of cognitive reserve on the progression of mild cognitive impairment to Alzheimer's disease in Japan.
    Osone A; Arai R; Hakamada R; Shimoda K
    Geriatr Gerontol Int; 2015 Apr; 15(4):428-34. PubMed ID: 24730644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of lifestyle-related disease on conversion and reversion in patients with mild cognitive impairment: after 12 months of follow-up.
    Osone A; Arai R; Hakamada R; Shimoda K
    Int J Geriatr Psychiatry; 2016 Jul; 31(7):740-8. PubMed ID: 26593034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia.
    Kile S; Au W; Parise C; Rose K; Donnel T; Hankins A; Chan M; Ghassemi A
    J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):106-112. PubMed ID: 26420886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment.
    Ten Kate M; Barkhof F; Visser PJ; Teunissen CE; Scheltens P; van der Flier WM; Tijms BM
    Alzheimers Res Ther; 2017 Sep; 9(1):73. PubMed ID: 28899429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer's disease and reverting to normal cognition.
    Tokuchi R; Hishikawa N; Kurata T; Sato K; Kono S; Yamashita T; Deguchi K; Abe K
    J Neurol Sci; 2014 Nov; 346(1-2):288-92. PubMed ID: 25248955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Searching for Primary Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Multivariate Follow-Up Study.
    López ME; Turrero A; Cuesta P; López-Sanz D; Bruña R; Marcos A; Gil P; Yus M; Barabash A; Cabranes JA; Maestú F; Fernández A
    J Alzheimers Dis; 2016 Mar; 52(1):133-43. PubMed ID: 27060953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the effect of cognitive/brain reserve and depression on regional atrophy in early Alzheimer's disease.
    Capogna E; Manca R; De Marco M; Hall A; Soininen H; Venneri A
    Postgrad Med; 2019 Sep; 131(7):533-538. PubMed ID: 31478419
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
    Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
    J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease.
    Persson K; Barca ML; Eldholm RS; Cavallin L; Šaltytė Benth J; Selbæk G; Brækhus A; Saltvedt I; Engedal K
    Dement Geriatr Cogn Disord; 2017; 44(1-2):12-24. PubMed ID: 28614836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proxies of cognitive reserve and their effects on neuropsychological performance in patients with mild cognitive impairment.
    Liu Y; Cai ZL; Xue S; Zhou X; Wu F
    J Clin Neurosci; 2013 Apr; 20(4):548-53. PubMed ID: 23406880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A neuroimaging approach to capture cognitive reserve: Application to Alzheimer's disease.
    van Loenhoud AC; Wink AM; Groot C; Verfaillie SCJ; Twisk J; Barkhof F; van Berckel B; Scheltens P; van der Flier WM; Ossenkoppele R
    Hum Brain Mapp; 2017 Sep; 38(9):4703-4715. PubMed ID: 28631336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Entorhinal Cortex Atrophy Score Is Diagnostic and Prognostic in Mild Cognitive Impairment.
    Traschütz A; Enkirch SJ; Polomac N; Widmann CN; Schild HH; Heneka MT; Hattingen E
    J Alzheimers Dis; 2020; 75(1):99-108. PubMed ID: 32250289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tracking Cognitive Decline in Amnestic Mild Cognitive Impairment and Early-Stage Alzheimer Dementia: Mini-Mental State Examination versus Neuropsychological Battery.
    Kim J; Na HK; Byun J; Shin J; Kim S; Lee BH; Na DL
    Dement Geriatr Cogn Disord; 2017; 44(1-2):105-117. PubMed ID: 28768247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive Reserve and Mild Cognitive Impairment: Predictors and Rates of Reversion to Intact Cognition vs Progression to Dementia.
    Iraniparast M; Shi Y; Wu Y; Zeng L; Maxwell CJ; Kryscio RJ; St John PD; SantaCruz KS; Tyas SL
    Neurology; 2022 Mar; 98(11):e1114-e1123. PubMed ID: 35121669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White matter disease independently predicts progression from mild cognitive impairment to Alzheimer's disease in a clinic cohort.
    Prasad K; Wiryasaputra L; Ng A; Kandiah N
    Dement Geriatr Cogn Disord; 2011; 31(6):431-4. PubMed ID: 21757908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of cognitive reserve on clinical and neuropsychological measures in patients with mild cognitive impairment.
    Haussmann R; von Lieres Und Wilkau AFE; Sauer C; Nilles F; Donix M
    Australas Psychiatry; 2020 Aug; 28(4):386-390. PubMed ID: 32174124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.